US Broker Ratings

Standard BioTools Inc. (LAB) Stock Analysis: Navigating Opportunities in Healthcare’s Evolving Landscape

Standard BioTools Inc. (NASDAQ: LAB) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. Headquartered in South San Francisco, California, the company specializes in developing..

Tectonic Therapeutic, Inc. (TECX): Investor Outlook on a Potential 275% Upside in Biotechnology

Tectonic Therapeutic, Inc. (NASDAQ: TECX) is drawing significant attention from investors, particularly those with an eye on the biotechnology sector. With a potential upside of 275.19%, this Watertown, Massachusetts-based company..

Celcuity Inc. (CELC) Stock Analysis: Exploring the Growth Potential in Biotech with a $4.9 Billion Market Cap

Celcuity Inc. (CELC), a prominent player in the biotechnology sector, has captured investor attention with its strong market presence and a promising pipeline of targeted therapies. Based in Minneapolis, Minnesota,..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating Challenges with Innovative Healthcare Solutions

Surmodics, Inc. (NASDAQ: SRDX) stands at the intersection of innovation and the medical devices industry, offering a range of performance coating technologies for intravascular medical devices and in vitro diagnostic..

Bicara Therapeutics Inc. (BCAX) Stock Analysis: Exploring a 73% Potential Upside in Biotech Innovation

Bicara Therapeutics Inc. (NASDAQ: BCAX) is drawing significant attention from investors and analysts alike, thanks to its promising position within the biotechnology sector. As a clinical-stage biopharmaceutical company, Bicara is..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Is This Healthcare Innovator a Buy with Its Strong Analyst Ratings?

For investors eyeing the healthcare sector, Castle Biosciences, Inc. (NASDAQ: CSTL) is a name that stands out, especially given its innovative approach in the diagnostics and research industry. Specializing in..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating a 15.10% Revenue Growth in Senior Care

InnovAge Holding Corp. (NASDAQ: INNV), a prominent player in the healthcare sector, specifically in medical care facilities, is making intriguing strides in the realm of senior care. With a market..

COMPASS Pathways (CMPS) Stock Analysis: A 199% Potential Upside in the Mental Health Revolution

COMPASS Pathways Plc – American (NASDAQ: CMPS) is making waves in the healthcare sector, particularly in the niche field of mental health treatment. With a market capitalization of approximately $545.38..

AbCellera Biologics Inc. (ABCL) Stock Analysis: Valuation Insights and 169% Potential Upside

AbCellera Biologics Inc. (NASDAQ: ABCL), a prominent player in the biotechnology industry, is drawing significant attention from investors due to its remarkable growth potential and robust pipeline. Headquartered in Vancouver,..

Septerna, Inc. (SEPN) Stock Analysis: Exploring a 11.81% Upside in Biotech Innovation

Septerna, Inc. (NASDAQ: SEPN) presents a compelling case for investors seeking exposure to biotech innovation, particularly within the realm of G protein-coupled receptor (GPCR) technologies. With a market capitalization of..

Neuropace, Inc. (NPCE) Stock Analysis: Strong Buy Ratings and Promising Revenue Growth in the Medical Device Sector

Neuropace, Inc. (NASDAQ: NPCE), headquartered in Mountain View, California, is making waves in the healthcare sector with its innovative medical devices. Specializing in the treatment of drug-resistant focal epilepsy, Neuropace..

Nutex Health Inc. (NUTX) Stock Analysis: Exploring a 59.45% Potential Upside in the Healthcare Sector

Nutex Health Inc. (NUTX) stands out as a promising player in the healthcare sector, particularly in the niche of medical care facilities. Headquartered in Houston, Texas, Nutex Health operates through..

Evolus, Inc. (EOLS) Stock Analysis: Potential for 171% Upside in the Healthcare Sector

Investors eyeing the healthcare sector for promising opportunities might want to consider Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on cash-pay aesthetic products. Evolus, headquartered in..

Immunome, Inc. (IMNM) Stock Analysis: A Biotech Gem with 27.76% Potential Upside

Immunome, Inc. (NASDAQ: IMNM) is capturing the attention of investors with its promising pipeline of cancer therapies and a notable potential upside of 27.76%. As a clinical-stage biotechnology company, Immunome..

ArriVent BioPharma, Inc. (AVBP): Analyst Consensus on 63% Upside Potential

ArriVent BioPharma, Inc. (NASDAQ: AVBP), a promising player in the biotechnology sector, has captured significant attention from investors, particularly due to its focus on addressing unmet medical needs in oncology...

Tourmaline Bio, Inc. (TRML) Stock Analysis: Navigating Biotech Innovation with a Steady Market Cap

Tourmaline Bio, Inc. (NASDAQ: TRML) is carving out a niche in the competitive biotechnology sector, focusing on groundbreaking therapies for life-altering immune and inflammatory diseases. With a current market capitalization..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: A 72.76% Potential Upside Awaits Investors

Organogenesis Holdings Inc. (NASDAQ: ORGO) is making waves in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $624.41 million, the company..

AMN Healthcare Services Inc (AMN) Stock Analysis: Exploring a 25% Potential Upside

AMN Healthcare Services Inc. (AMN) is a prominent player in the healthcare sector, specializing in medical care facilities. With a market capitalization of $636.52 million, the company is a significant..

Pharvaris N.V. (PHVS) Stock Analysis: Exploring a 65.95% Potential Upside in Biotech Innovation

Pharvaris N.V. (PHVS), a Swiss-based biopharmaceutical company, is capturing the attention of investors with its promising pipeline in the biotechnology sector. Specializing in therapies for rare diseases, Pharvaris focuses on..

Auna SA (AUNA) Investor Outlook: Exploring a 115% Potential Upside in the Healthcare Sector

Auna SA (AUNA), a prominent player in the healthcare sector, draws investor attention with its significant potential upside of 115.05%, as indicated by its average target price. Operating hospitals and..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds